1.14
price down icon1.72%   -0.02
after-market Handel nachbörslich: 1.14
loading
Schlusskurs vom Vortag:
$1.16
Offen:
$1.15
24-Stunden-Volumen:
74,715
Relative Volume:
0.16
Marktkapitalisierung:
$56.86M
Einnahmen:
$96.63M
Nettoeinkommen (Verlust:
$-63.32M
KGV:
-0.7808
EPS:
-1.46
Netto-Cashflow:
$-54.55M
1W Leistung:
-8.06%
1M Leistung:
-8.80%
6M Leistung:
-44.93%
1J Leistung:
-44.12%
1-Tages-Spanne:
Value
$1.12
$1.17
1-Wochen-Bereich:
Value
$1.09
$1.255
52-Wochen-Spanne:
Value
$0.931
$3.42

Akoya Biosciences Inc Stock (AKYA) Company Profile

Name
Firmenname
Akoya Biosciences Inc
Name
Telefon
855.896.8401
Name
Adresse
100 CAMPUS DRIVE, MARLBOROUGH
Name
Mitarbeiter
205
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-17
Name
Neueste SEC-Einreichungen
Name
AKYA's Discussions on Twitter

Vergleichen Sie AKYA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Instruments & Supplies icon
AKYA
Akoya Biosciences Inc
1.14 61.85M 96.63M -63.32M -54.55M -1.46
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
558.06 199.19B 8.71B 2.48B 1.75B 6.82
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
171.03 49.82B 20.87B 1.50B 2.59B 5.24
Medical Instruments & Supplies icon
ALC
Alcon Inc
86.93 42.71B 9.93B 1.12B 1.58B 2.25
Medical Instruments & Supplies icon
RMD
Resmed Inc
249.69 35.94B 5.02B 1.31B 1.56B 8.91
Medical Instruments & Supplies icon
WST
West Pharmaceutical Services Inc
218.58 15.12B 2.90B 467.20M 306.90M 6.37

Akoya Biosciences Inc Stock (AKYA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-11-15 Herabstufung Craig Hallum Buy → Hold
2024-08-06 Herabstufung BTIG Research Buy → Neutral
2024-08-06 Herabstufung JP Morgan Overweight → Neutral
2024-08-06 Herabstufung Morgan Stanley Overweight → Equal-Weight
2024-06-21 Eingeleitet Craig Hallum Buy
2023-12-14 Eingeleitet Guggenheim Neutral
2023-07-05 Fortgesetzt JP Morgan Overweight
2023-02-02 Eingeleitet UBS Buy
2022-11-03 Eingeleitet CapitalOne Overweight
2022-10-06 Eingeleitet Stephens Overweight
2022-06-22 Eingeleitet BTIG Research Buy
2022-01-06 Fortgesetzt Piper Sandler Overweight
2021-05-11 Eingeleitet Canaccord Genuity Buy
2021-05-11 Eingeleitet JP Morgan Overweight
2021-05-11 Eingeleitet Morgan Stanley Overweight
2021-05-11 Eingeleitet Piper Sandler Overweight
Alle ansehen

Akoya Biosciences Inc Aktie (AKYA) Neueste Nachrichten

pulisher
Jun 04, 2025

Deutsche Bank AG Raises Stock Holdings in Akoya Biosciences, Inc. (NASDAQ:AKYA) - Defense World

Jun 04, 2025
pulisher
Jun 02, 2025

Akoya Biosciences (AKYA) Receives Price Target Cut from Morgan Stanley | AKYA Stock News - GuruFocus

Jun 02, 2025
pulisher
May 31, 2025

Northern Trust Corp Buys 39,799 Shares of Akoya Biosciences, Inc. (NASDAQ:AKYA) - Defense World

May 31, 2025
pulisher
May 30, 2025

Spatial proteomics Market Worth Observing Growth: Bruker, Akoya Biosciences, PerkinElmer - newstrail.com

May 30, 2025
pulisher
May 29, 2025

Spatiotemporal Omics Market Research Report 2025-2035, Competitive Analysis of Prominent Players10X Genomics, Akoya Biosciences, Bruker, Curio Bioscience, IonPath, MGI, and RareCyteResearchAndMarkets.com - FinancialContent

May 29, 2025
pulisher
May 29, 2025

Akoya Biosciences, Inc. (NASDAQ:AKYA) Receives Average Recommendation of “Hold” from Brokerages - Defense World

May 29, 2025
pulisher
May 23, 2025

New Data and Deal Flow Signal a Turning Point for Precision-Driven Cancer Biotechs - Benzinga

May 23, 2025
pulisher
May 21, 2025

Akoya Biosciences (AKYA) Soars on New Acquisition Proposal - GuruFocus

May 21, 2025
pulisher
May 21, 2025

An undisclosed buyer agreed to acquire Akoya Biosciences, Inc.. - marketscreener.com

May 21, 2025
pulisher
May 21, 2025

Akoya Biosciences Receives Unsolicited Buyout Offer From Third Party - marketscreener.com

May 21, 2025
pulisher
May 21, 2025

Akoya stock surges as new buyout bid risks Quanterix deal (AKYA) - Seeking Alpha

May 21, 2025
pulisher
May 21, 2025

Akoya Biosciences reviews unsolicited acquisition proposal By Investing.com - Investing.com Nigeria

May 21, 2025
pulisher
May 21, 2025

Akoya Biosciences IncOn May 20, Receives Unsolicited Acquisition Proposal At $1.40 Per Share From A Third Party- SEC Filing - marketscreener.com

May 21, 2025
pulisher
May 21, 2025

Akoya Biosciences reviews unsolicited acquisition proposal - Investing.com

May 21, 2025
pulisher
May 20, 2025

Akoya Biosciences (NASDAQ:AKYA) Given New $1.08 Price Target at Canaccord Genuity Group - Defense World

May 20, 2025
pulisher
May 20, 2025

Akoya Biosciences Reports Q1 2025 Financial Results - TipRanks

May 20, 2025
pulisher
May 19, 2025

Akoya Biosciences (AKYA) Target Price Reduced by Canaccord | AKY - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Akoya Biosciences (AKYA): Analyst Lowers Price Target | AKYA Sto - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Akoya Biosciences (AKYA): Analyst Lowers Price Target | AKYA Stock News - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Akoya Biosciences (AKYA) Target Price Reduced by Canaccord | AKYA Stock News - GuruFocus

May 19, 2025
pulisher
May 13, 2025

Akoya Biosciences (AKYA) Faces Uncertainty Amid Merger and Marke - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Akoya Biosciences, Inc. SEC 10-Q Report - TradingView

May 13, 2025
pulisher
May 12, 2025

Akoya: Q1 Earnings Snapshot - The Washington Post

May 12, 2025
pulisher
May 12, 2025

Akoya Biosciences earnings missed by $0.11, revenue fell short of estimates - Investing.com Canada

May 12, 2025
pulisher
May 12, 2025

Akoya Biosciences (AKYA) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance

May 12, 2025
pulisher
May 12, 2025

Akoya Biosciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 12, 2025
pulisher
May 12, 2025

Akoya Biosciences Inc Reports Q1 2025 Earnings: EPS of -$0.18 Be - GuruFocus

May 12, 2025
pulisher
May 12, 2025

Akoya Biosciences Reports First Quarter 2025 Financial Results - The Manila Times

May 12, 2025
pulisher
May 10, 2025

Akoya Biosciences (AKYA) Projected to Post Quarterly Earnings on Monday - Defense World

May 10, 2025
pulisher
May 07, 2025

AKOYA BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc.AKYA - Business Wire

May 07, 2025
pulisher
May 06, 2025

Akoya Biosciences, Inc. (NASDAQ:AKYA) Shares Acquired by JPMorgan Chase & Co. - Defense World

May 06, 2025
pulisher
May 05, 2025

Quanterix and Akoya Biosciences Announce Amended Merger Agreement - ADVFN

May 05, 2025
pulisher
May 05, 2025

Akoya Biosciences (AKYA) May Report Negative Earnings: Know the Trend Ahead of Q1 Release - Yahoo Finance

May 05, 2025
pulisher
May 04, 2025

Akoya Biosciences, Inc. (NASDAQ:AKYA) Given Average Recommendation of “Hold” by Analysts - Defense World

May 04, 2025
pulisher
May 01, 2025

Canaccord Genuity Group Has Lowered Expectations for Akoya Biosciences (NASDAQ:AKYA) Stock Price - Defense World

May 01, 2025
pulisher
Apr 30, 2025

AKYA Merger Faces Backlash Amid Shareholder Discontent | AKYA St - GuruFocus

Apr 30, 2025
pulisher
Apr 30, 2025

Quanterix Acquisition of Akoya Biosciences (AKYA) Faces Challenges | AKYA Stock News - GuruFocus

Apr 30, 2025
pulisher
Apr 30, 2025

Kent Lake Issues Statement on Quanterix?s Amendment to Merger with Akoya Biosciences - marketscreener.com

Apr 30, 2025
pulisher
Apr 29, 2025

Quanterix, Akoya Biosciences Amend Merger Deal - marketscreener.com

Apr 29, 2025
pulisher
Apr 29, 2025

Akoya stock falls on amended Quanterix merger deal (AKYA) - Seeking Alpha

Apr 29, 2025
pulisher
Apr 29, 2025

Quanterix Revises Merger Terms with Akoya Biosciences - TipRanks

Apr 29, 2025
pulisher
Apr 29, 2025

Merger Amendment: Changes to Quanterix and Akoya Biosciences (AK - GuruFocus

Apr 29, 2025
pulisher
Apr 29, 2025

Quanterix And Akoya Biosciences Announce Amended Merger Agreement - marketscreener.com

Apr 29, 2025
pulisher
Apr 29, 2025

Canaccord Adjusts Price Target for Akoya Biosciences (AKYA) | AK - GuruFocus

Apr 29, 2025
pulisher
Apr 24, 2025

Akoya Biosciences introduces new assay for breast cancer ADC development By Investing.com - Investing.com South Africa

Apr 24, 2025
pulisher
Apr 24, 2025

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Pacific Premier Bancorp, Inc. (NasdaqPPBI), Southern States Bancshares, Inc. (NasdaqSSBK), Akoya Biosciences, Inc. (NasdaqAKYA) - TradingView

Apr 24, 2025
pulisher
Apr 24, 2025

Akoya Biosciences (AKYA) Unveils New Assay for Breast Cancer Res - GuruFocus

Apr 24, 2025
pulisher
Apr 24, 2025

Akoya Biosciences (AKYA) Unveils New Assay for Breast Cancer Research | AKYA Stock News - GuruFocus

Apr 24, 2025
pulisher
Apr 24, 2025

Akoya Biosciences introduces new assay for breast cancer ADC development - Investing.com Australia

Apr 24, 2025
pulisher
Apr 24, 2025

Akoya Biosciences Expands Biopharma Service Portfolio with New ADC Breast Cancer Assay and Real-world IO60 Insights at AACR 2025 - The Manila Times

Apr 24, 2025
pulisher
Apr 24, 2025

Akoya Biosciences Expands Biopharma Service Portfolio with - GlobeNewswire

Apr 24, 2025

Finanzdaten der Akoya Biosciences Inc-Aktie (AKYA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Akoya Biosciences Inc-Aktie (AKYA) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
McKelligon Brian
President and CEO
Jun 11 '24
Sale
2.08
7,500
15,630
224,733
McKelligon Brian
President and CEO
Jun 06 '24
Option Exercise
0.30
7,500
2,272
232,233
McKelligon Brian
President and CEO
Jun 06 '24
Sale
2.01
7,500
15,064
224,733
$75.37
price up icon 0.31%
$180.26
price up icon 0.15%
$63.07
price up icon 0.80%
medical_instruments_supplies COO
$71.18
price up icon 5.58%
medical_instruments_supplies BAX
$30.15
price up icon 0.60%
medical_instruments_supplies WST
$218.58
price up icon 3.38%
Kapitalisierung:     |  Volumen (24h):